Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.

Realini N, Rubino T, Parolaro D.

Pharmacol Res. 2009 Aug;60(2):132-8. doi: 10.1016/j.phrs.2009.03.006. Epub 2009 Mar 17. Review.

PMID:
19559364
2.

Long lasting consequences of cannabis exposure in adolescence.

Rubino T, Parolaro D.

Mol Cell Endocrinol. 2008 Apr 16;286(1-2 Suppl 1):S108-13. doi: 10.1016/j.mce.2008.02.003. Epub 2008 Feb 13. Review.

PMID:
18358595
3.
4.

Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.

Malone DT, Hill MN, Rubino T.

Br J Pharmacol. 2010 Jun;160(3):511-22. doi: 10.1111/j.1476-5381.2010.00721.x. Review.

5.

Long-term consequences of adolescent cannabinoid exposure in adult psychopathology.

Renard J, Krebs MO, Le Pen G, Jay TM.

Front Neurosci. 2014 Nov 10;8:361. doi: 10.3389/fnins.2014.00361. eCollection 2014. Review.

6.

Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.

Schneider M.

Addict Biol. 2008 Jun;13(2):253-63. doi: 10.1111/j.1369-1600.2008.00110.x. Review.

PMID:
18482434
7.

Cannabis abuse in adolescence and the risk of psychosis: a brief review of the preclinical evidence.

Rubino T, Parolaro D.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jul 3;52:41-4. doi: 10.1016/j.pnpbp.2013.07.020. Epub 2013 Aug 1. Review.

PMID:
23916409
8.

Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.

Bossong MG, Niesink RJ.

Prog Neurobiol. 2010 Nov;92(3):370-85. doi: 10.1016/j.pneurobio.2010.06.010. Epub 2010 Jul 16. Review.

PMID:
20624444
10.

Adolescent exposure to cannabis as a risk factor for psychiatric disorders.

Rubino T, Zamberletti E, Parolaro D.

J Psychopharmacol. 2012 Jan;26(1):177-88. doi: 10.1177/0269881111405362. Epub 2011 Jul 18. Review.

PMID:
21768160
11.

Cannabis and adolescent brain development.

Lubman DI, Cheetham A, YĆ¼cel M.

Pharmacol Ther. 2015 Apr;148:1-16. doi: 10.1016/j.pharmthera.2014.11.009. Epub 2014 Nov 20. Review.

PMID:
25460036
12.

Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents.

Campolongo P, Trezza V, Ratano P, Palmery M, Cuomo V.

Psychopharmacology (Berl). 2011 Mar;214(1):5-15. doi: 10.1007/s00213-010-1892-x. Epub 2010 Jun 17. Review.

13.
14.

Cannabis and psychiatric disorders: it is not only addiction.

Leweke FM, Koethe D.

Addict Biol. 2008 Jun;13(2):264-75. doi: 10.1111/j.1369-1600.2008.00106.x. Review.

PMID:
18482435
15.

Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations.

Campolongo P, Trezza V, Palmery M, Trabace L, Cuomo V.

Int Rev Neurobiol. 2009;85:117-33. doi: 10.1016/S0074-7742(09)85009-5. Review.

PMID:
19607965
16.

Evidence for the Risks and Consequences of Adolescent Cannabis Exposure.

Levine A, Clemenza K, Rynn M, Lieberman J.

J Am Acad Child Adolesc Psychiatry. 2017 Mar;56(3):214-225. doi: 10.1016/j.jaac.2016.12.014. Epub 2016 Dec 29. Review.

PMID:
28219487
17.

Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model.

Adriani W, Laviola G.

Behav Pharmacol. 2004 Sep;15(5-6):341-52. Review.

PMID:
15343057
18.

The Impact of Exposure to Cannabinoids in Adolescence: Insights From Animal Models.

Rubino T, Parolaro D.

Biol Psychiatry. 2016 Apr 1;79(7):578-85. doi: 10.1016/j.biopsych.2015.07.024. Epub 2015 Aug 7. Review.

PMID:
26344755
19.

Cannabis and the developing brain: insights from behavior.

Trezza V, Cuomo V, Vanderschuren LJ.

Eur J Pharmacol. 2008 May 13;585(2-3):441-52. doi: 10.1016/j.ejphar.2008.01.058. Epub 2008 Mar 18. Review.

PMID:
18413273
20.

Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome.

Jutras-Aswad D, DiNieri JA, Harkany T, Hurd YL.

Eur Arch Psychiatry Clin Neurosci. 2009 Oct;259(7):395-412. doi: 10.1007/s00406-009-0027-z. Epub 2009 Jul 2. Review.

PMID:
19568685

Supplemental Content

Support Center